SMLR Company Profile and Key Details

Semler Scientific, Inc. (NASDAQ:SMLR) closed at $20.33 USD, losing -$1.04 (-4.87%) from the previous close of $21.37. The stock is currently mid-range between its 52-week high and low $14.88 and $65.98. With a market capitalization of about $310.75 million, Semler Scientific, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.32). Key stats such as the average daily volume over the past year has been around 647.86 thousand shares, trading with heavier-than-usual volume. Headquartered in Santa Clara, CA, Semler Scientific, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Douglas Murphy-Chutorian, the company employs approximately 79 people and listed since February 21, 2014. Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.

SMLR has shown mixed momentum, losing -1.64% over the past week and -20.18% over the past quarter, though year-to-date performance is up 32.96%. Short-term trend indicators are bullishly aligned (SMA20 9.42%, SMA50 -0.25%, SMA200 -33.0%). The stock’s 14-day RSI is 52.28 (neutral), while the ATR of 2.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -69.43% below its high and over 36.58% above its low.

Semler Scientific, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $19.14. This means the shares are trading above this model’s fair value.

Semler Scientific, Inc. generated EPS of $2.78 over the past year. Five-year average earnings growth is 22.23%. The latest quarter delivered EPS of $3.41. The next quarter is forecast at $nan. Next year's EPS is expected at $25.58. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $101.00 to $60.00. The high target offers 396.8% upside. The low target suggests 195.13% downside. The mean target is $80.50. This offers 295.97% upside. Semler Scientific, Inc. earnings surprise history is a mixed track record. The quarter that ended February 17, 2026, missed forecasts by -731.48%. The prior quarter beat by -621.95%. Over the last six quarters, Apple has recorded several small beats. These include -99.75% in August 05, 2024.

Semler Scientific, Inc. has 14.80 million shares outstanding. The public float is 13.00 million shares, elevated short interest at 17.53% of float. This equals 2.29 million shares. The short ratio is 3.58 days. Institutional investors hold 74.81% of the float. Insiders own 12.15%. SEMLER ERIC holds 77.77 thousand shares, Murphy-Chutorian Douglas has 54.59 thousand shares and Pan Wayne T has 43.78 thousand shares. Over the past six months, insider transactions show net selling. They sold 12.74 thousand shares across 1 transactions.